BMY vs ABBV
BMY 与 ABBV 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | BMYBRISTOL-MYERS SQUIBB COMPANY | ABBVAbbVie Inc. |
|---|---|---|
| 市值 | $128.34B | $466.64B |
| 市盈率(TTM) | 13.8 | 74.6 |
| 市净率 | 5.75 | — |
| 市销率 | 2.7x | 7.6x |
| 股息率 | 3.93% | 2.50% |
| 营收 | $49.19B(TTM) | $61.16B(TTM) |
| 营收同比增长 | -0.2% | 8.6% |
| 净利润 | $9.28B(TTM) | $6.31B(TTM) |
| 净利同比增长 | 178.8% | -1.2% |
| 每股收益(稀释) | $4.54(TTM) | $3.54(TTM) |
| 息税前利润率 | 21.8% | 24.6% |
| 净资产收益率 | 31.6% | — |
| 投入资本回报率 | 14.0% | 18.6% |
| 皮氏F值 | 7/9 | — |
| 一年总回报 | +41.5% | +22.6% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:BMY vs ABBV
| 指标 | BMY | ABBV |
|---|---|---|
| 期末价值 | $12.3K | $64.3K |
| 总回报 | +23.4% | +542.9% |
| 年化收益 (CAGR) | +2.1% | +19.7% |
| 波动率 | 25.3% | 25.9% |
| 夏普比率 | 0.04 | 0.67 |
| 索提诺比率 | 0.06 | 0.93 |
| 最大回撤 | -47.7% | -45.1% |
基于 2600 个共同交易日,2016-05-16 → 2026-09-17 · 无风险利率 4.14%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)